Evidence map›Paper›PMID 36139721›Full record

ArticleAntioxidants (Basel, Switzerland)2022

Development and Evaluation of

Glaucimeire R Carvalho, Débora S Braz, Talita C O Gonçalves, Rafaela Aires, Larissa Z Côco, Marcio Guidoni, Marcio Fronza, Denise C Endringer, Antonio D S Júnior, Manuel Campos-Toimil and 4 more

Abstract read
In one paragraph

Article in Antioxidants (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Plant Extracts as Skin Care and Therapeutic Agents.International journal of molecular sciences · 2023
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Glaucimeire R CarvalhoPharmaceutical Sciences Graduate Program, Vila Velha University (UVV), Vila Velha 29102-920, Brazil.
Débora S BrazPharmaceutical Sciences Graduate Program, Vila Velha University (UVV), Vila Velha 29102-920, Brazil.
Talita C O GonçalvesPharmaceutical Sciences Graduate Program, Vila Velha University (UVV), Vila Velha 29102-920, Brazil.
Rafaela AiresPharmaceutical Sciences Graduate Program, Vila Velha University (UVV), Vila Velha 29102-920, Brazil.
Larissa Z CôcoPharmaceutical Sciences Graduate Program, Vila Velha University (UVV), Vila Velha 29102-920, Brazil.
Marcio GuidoniPharmaceutical Sciences Graduate Program, Vila Velha University (UVV), Vila Velha 29102-920, Brazil.ORCID 0000-0003-1834-4226
Marcio FronzaPharmaceutical Sciences Graduate Program, Vila Velha University (UVV), Vila Velha 29102-920, Brazil.
Denise C EndringerPharmaceutical Sciences Graduate Program, Vila Velha University (UVV), Vila Velha 29102-920, Brazil.ORCID 0000-0001-9396-2097
Antonio D S JúniorPharmaceutical Sciences Graduate Program, Vila Velha University (UVV), Vila Velha 29102-920, Brazil.
Manuel Campos-ToimilPhysiology and Pharmacology of Chronic Diseases (FIFAEC), Center for Research in Molecular Medicine and Chronic Diseases (CiMUS), University of Santiago de Compostela, 15782 Santiago de Compostela, Spain.ORCID 0000-0003-3674-3749
Breno V NogueiraLaboratory of Translational Physiology, Physiological Sciences Graduate Program, Federal University of Espírito Santo, Vitoria 29047-105, Brazil.
Elisardo C VasquezPharmaceutical Sciences Graduate Program, Vila Velha University (UVV), Vila Velha 29102-920, Brazil.
Bianca P CampagnaroPharmaceutical Sciences Graduate Program, Vila Velha University (UVV), Vila Velha 29102-920, Brazil.
Thiago M C PereiraPharmaceutical Sciences Graduate Program, Vila Velha University (UVV), Vila Velha 29102-920, Brazil.ORCID 0000-0003-4053-5061

Funding

Coordenação de Aperfeicoamento de Pessoal de Nível Superior scholarship to GRC - 001Fundação de Amparo à Pesquisa do Espírito Santo scholarship to LZC; grants to BPC - 552/2018 and 120/2019National Council for Scientific and Technological Development ECV 305740/2019-9National Council for Scientific and Technological Development TMCP 309277/2019-1
6 · The paper itself

Abstract

In regions adjacent to the Brazilian Atlantic Forest, Virola oleifera (VO) resin extract has been popularly used for decades as a skin and mucosal healing agent. However, this antioxidant-rich resin has not yet been investigated in wound healing, whose physiological process might also be aggravated by oxidative stress-related diseases (e.g., hypertension/diabetes). Our aim, therefore, was to investigate whether VO resin presents healing effects through an innovative cream for topical applications. For this, adult male Wistar rats were divided into four groups. Then, four 15 mm excisions were performed on the shaved skin. All treatments were applied topically to the wound area daily. At the end of experiments (0, 3rd, and 10th days) macroscopic analysis of wound tissue contraction and histological analysis of inflammatory cell parameters were performed. The group treated with VO cream showed the best wound contraction (15%, p < 0.05) and reduced levels of lipid peroxidation and protein oxidation (118% and 110%, p < 0.05, respectively) compared to the control group. Our results demonstrated the healing capacity of a new formulation prepared with VO, which could be, at least in part, justified by antioxidant mechanisms that contribute to re-epithelialization, becoming a promising dermo-cosmetic for the treatment of wound healing.

Indexed as

antioxidantbicuíbahealingoxidative stressplant extractpolyphenolsreepithelization

Identifiers

PMID36139721
PMCPMC9495449

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.